EconBiz - Find Economic Literature
    • Logout
    • Change account settings
  • A-Z
  • Beta
  • About EconBiz
  • News
  • Thesaurus (STW)
  • Academic Skills
  • Help
  •  My account 
    • Logout
    • Change account settings
  • Login
EconBiz - Find Economic Literature
Publications Events
Search options
Advanced Search history
My EconBiz
Favorites Loans Reservations Fines
    You are here:
  • Home
  • Search: subject:"Catechol O methyltransferase inhibitors"
Narrow search

Narrow search

Year of publication
Subject
All
Acetylcholine receptor antagonists 2 Amantadine 2 Catechol O methyltransferase inhibitors 2 Dopamine receptor agonists 2 Entacapone 2 Levodopa 2 Parkinson's disease 2 Antiparkinsonians 1 Bromocriptine 1 Cost analysis 1 Pergolide 1 Pharmacoeconomics 1 Pramipexole 1 Quality of life 1 Ropinirole 1 Selegiline 1 Surgery 1 Tolcapone 1
more ... less ...
Online availability
All
Undetermined 2
Type of publication
All
Article 2
Language
All
Undetermined 2
Author
All
Chrischilles, Elizabeth A. 1 DeLeo, Andrea 1 Goa, Karen L. 1 Ibbotson, Tim 1 Rubenstein, Linda M. 1
Published in...
All
Disease Management and Health Outcomes 1 PharmacoEconomics 1
Source
All
RePEc 2
Showing 1 - 2 of 2
Cover Image
Management of Parkinson's Disease: Defining the Role of Entacapone
Ibbotson, Tim; Goa, Karen L. - In: Disease Management and Health Outcomes 10 (2002) 10, pp. 643-659
Parkinson's disease, a movement disorder caused by degeneration of nigrostriatal dopaminergic neurons in the substantia nigra, is characterized by resting tremor, rigidity, bradykinesia and postural instability. For over 30 years levodopa has been considered as the first-line treatment for this...
Persistent link: https://www.econbiz.de/10005404687
Saved in:
Cover Image
Economic and Health-Related Quality of Life Considerations of New Therapies in Parkinson's Disease
Rubenstein, Linda M.; DeLeo, Andrea; Chrischilles, … - In: PharmacoEconomics 19 (2001) 7, pp. 729-752
The progressive disability of Parkinson's disease results in substantial burdens for patients, their families and society in terms of increased health resource use, poorer quality of life, caregiver burden, disrupted family relationships, decreases in social and leisure activities, deteriorating...
Persistent link: https://www.econbiz.de/10005590467
Saved in:
A service of the
zbw
  • Sitemap
  • Plain language
  • Accessibility
  • Contact us
  • Imprint
  • Privacy

Loading...